| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 02/21/2002 | CA2417152A1 Therapeutic compounds for ovarian cancer |
| 02/20/2002 | EP1180121A1 Long lasting insulinotropic peptides |
| 02/20/2002 | EP1180115A1 Minimal isolation peptide synthesis process using ion-exchange resins as scavenging agents |
| 02/20/2002 | EP0832120B1 Anti-fungal d-amino acid histatin-based peptides |
| 02/20/2002 | CN1336935A Compositions and methods for WT1 specific immunotherapy |
| 02/20/2002 | CN1336380A Anticancer polypeptide |
| 02/19/2002 | US6348580 Monoclonal antibody recognizing phosphatidylinositol-3,4,5-triphosphate |
| 02/19/2002 | US6348570 Tetrapeptides; diagnosing and monitoring inflammatory, nervous system, skin, cardiovascular, respiratory system, gastrointestinal, urogenital and immune disorders; evaluating inhibitors |
| 02/19/2002 | US6348568 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 02/19/2002 | US6348445 Biologically active peptides with reduced toxicity in animals and a method for preparing same |
| 02/19/2002 | US6348310 Quantitation of individual protein kinase activity |
| 02/19/2002 | CA2103889C Process for the phosphorylation of insulin and product produced thereby |
| 02/14/2002 | WO2002012286A2 Stress proteins and peptides and methods of use thereof |
| 02/14/2002 | WO2002012278A2 Pseudo-metalloproteins, corresponding preparation and use as biosensors |
| 02/14/2002 | WO2002012275A2 Lat peptides and their use in assays for identifying immunosuppressants |
| 02/14/2002 | WO2002012272A2 Therapeutic anti-melanoma compounds |
| 02/14/2002 | WO2002012271A2 Treatment of microbial infections with bacterial proteins and peptides |
| 02/14/2002 | WO2002012270A1 Peptides capable of functioning as mimotopes for estradiol analytes |
| 02/14/2002 | WO2001070766A3 Therapeutic anti-cytomegalovirus compounds |
| 02/14/2002 | WO2001064008A3 Vaccine for the treatment of artherosclerosis |
| 02/14/2002 | WO2001032906A3 Oligomers and oligomeric segments of alpha-hydroxy carboxylic acids and alpha-amino acids |
| 02/14/2002 | US20020019403 Inhibit amyloid protein deposits |
| 02/14/2002 | US20020019346 Treatment of prostate cancer by inhibiting lyn tyrosine kinase |
| 02/14/2002 | US20020019061 Purification and analysis of cyclic peptide libraries, and compositions thereof |
| 02/14/2002 | CA2419019A1 Pseudo-metalloproteins, corresponding preparation and use as biosensors |
| 02/14/2002 | CA2418445A1 Stress proteins and peptides and methods of use thereof |
| 02/14/2002 | CA2418131A1 Peptides capable of functioning as mimotopes for estradiol analytes |
| 02/14/2002 | CA2416890A1 Therapeutic anti-melanoma compounds |
| 02/13/2002 | EP1179538A1 Peptides blocking response to chemical substances or thermal stimuli or nociceptor inflammation mediators and compositions containing said peptides |
| 02/13/2002 | EP1179537A1 Solid phase peptide synthesis method |
| 02/13/2002 | EP1179186A2 Protein-protein interactions and methods for identifying interacting proteins and the amino acid sequence at the site of interaction |
| 02/13/2002 | EP1179059A1 Isolating biological modulators from biodiverse gene fragment libraries |
| 02/13/2002 | EP1179019A2 Immunogenic peptides derived from mage and the use thereof |
| 02/13/2002 | EP1179010A2 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 02/13/2002 | EP0866878A4 Detection of mammary tumor virus-like sequences in human breast cancer |
| 02/13/2002 | EP0703786B1 Use of nona- and decapeptides in the preparation of a drug for the treatment of aids |
| 02/13/2002 | EP0614379B1 Technetium-99m labeled peptides for imaging |
| 02/13/2002 | CN1335854A Compositions and methods for controlling plant pests |
| 02/13/2002 | CN1335853A Alpha v beta b integrin inhibitors |
| 02/12/2002 | US6346604 Method for controlling conformation of cyclopentapeptide |
| 02/12/2002 | US6346514 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 02/12/2002 | US6346512 Compounds and methods for modulating cell adhesion |
| 02/12/2002 | US6346413 Polymer arrays |
| 02/12/2002 | US6346390 Receptor derived peptides involved in modulation of response to ligand binding |
| 02/12/2002 | US6346375 NANBV diagnostics and vaccines |
| 02/12/2002 | CA2222810C Process for recovering water-insoluble compounds from a fermentation broth |
| 02/07/2002 | WO2002010201A2 Peptide-mediated delivery of molecules into cells |
| 02/07/2002 | WO2002010195A2 Modified peptides with increased potency |
| 02/07/2002 | WO2002010194A1 Substance p analogs for the treatment of cancer |
| 02/07/2002 | WO2002010193A1 Lipid-peptide conjugates for treatment of cancer |
| 02/07/2002 | WO2002010192A2 Somatostatin analogues |
| 02/07/2002 | WO2002009649A2 Cell internalized peptide-drug conjugates |
| 02/07/2002 | WO2002009508A1 Nonhuman animal models non-responsive to mycoplasma-origin lipoprotein/lipopeptide |
| 02/07/2002 | WO2001051506A3 Oligomers of nonpeptide restricted mimetics of dipeptides or tripeptides and the use thereof in the synthesis of synthetic proteins and polypeptides |
| 02/07/2002 | US20020016446 Recombinant vector and use thereof for exocellular preparation of single molecula antibodies from bacillus subtilis |
| 02/07/2002 | US20020016294 Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties |
| 02/07/2002 | US20020016291 Cyclic peptides as potent and selective melanocortin-4 receptor antagonists |
| 02/07/2002 | US20020016008 Conformationally-restricted peptide probe libraries |
| 02/07/2002 | US20020015680 A compound, comprising: a targeting moiety and a chelator, wherein the targeting moiety is bound to the chelator, is a qinolone nonpeptide, and binds to a receptor that is upregulated during angiogenesis |
| 02/07/2002 | CA2417885A1 Cell internalized peptide-drug conjugates |
| 02/07/2002 | CA2417454A1 Peptide-mediated delivery of molecules into cells |
| 02/07/2002 | CA2417100A1 Modified peptides with increased potency |
| 02/07/2002 | CA2405728A1 Lipid-peptide conjugates for treatment of cancer |
| 02/06/2002 | EP1177210A1 Peptides from the tt virus sequence and monospecific antibodies binding to the tt virus |
| 02/06/2002 | EP1177197A2 Polyamines and their use in therapy |
| 02/06/2002 | EP1176987A2 Short-chain peptide dye conjugates used as contrast agents for optical diagnostics |
| 02/06/2002 | EP1021200B1 Methods and compositions for treating rheumatoid arthritis |
| 02/06/2002 | EP0941478B1 Assay method for peptide specific t-cells |
| 02/05/2002 | US6344551 Contulakin-G, analogs thereof and uses therefor |
| 02/05/2002 | US6344544 Semaphorin-specific antibodies |
| 02/05/2002 | US6344442 Biodegradable inserts |
| 02/05/2002 | US6344439 Agents for promoting bone formation |
| 02/05/2002 | US6344436 Gene delivery to cells |
| 02/05/2002 | US6344318 A selex method determining three dimensional structure of nucleic acid ligands by identifying a ligand to a specific target and modifying the nucleotides with a monomer to allow the ligand to mimic the structure and bind the target |
| 02/05/2002 | US6344203 Mimicking peptides in cancer therapy |
| 02/05/2002 | CA2127284C Protein- and peptide-metal ion pharmaceutical applications |
| 02/05/2002 | CA2057612C Selected peptides of the group-specific antigen (gag) of human immunodeficiency virus (hiv), the preparation and use thereof |
| 01/31/2002 | WO2002008256A2 Peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | WO2002008251A2 Peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | WO2002008250A2 Ghrelin antagonists |
| 01/31/2002 | WO2002008247A2 Process for the preparation of 5-phenylpentanoyl-ala-argl-{2-[3-amino-2-oxopyrrolidin-1-yl]propionyl}-ala-arg-ala-4-aminophenylacetamide |
| 01/31/2002 | WO2002008244A2 Peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | WO2002008198A2 Novel imidazolidinones as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | WO2002008187A1 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | WO2002007779A1 Long wavelength long lifetime luminophores |
| 01/31/2002 | WO2002007773A2 Multi-component biological transport systems |
| 01/31/2002 | WO2002007770A2 Polymeric conjugates of antitumor agents |
| 01/31/2002 | WO2002007759A2 Clostridial toxin derivatives and methods for treating pain |
| 01/31/2002 | WO2002007676A2 Compounds having affinity for the granulocyte-colony stimulating factor receptor (g-csfr) |
| 01/31/2002 | WO2001083693A8 Compounds having affinity for the vascular endothelial growth factor receptor-2 (vegfr-2) and associated uses |
| 01/31/2002 | WO2001080873A3 Thrombopoietin receptor modulating peptide |
| 01/31/2002 | WO2001068120A3 Uses of bombesin receptor 3 |
| 01/31/2002 | WO2001062775A3 Novel antiarrhythmic peptides |
| 01/31/2002 | WO2001061017A3 Modified cytokines for use in cancer therapy |
| 01/31/2002 | WO2001053322A3 Aerothricin analogs, their preparation and use |
| 01/31/2002 | WO2001044284A3 Chimeric natriuretic peptides |
| 01/31/2002 | US20020013274 Administering a covalently reactive antigen analog (CRAA) having an an epitope recognized irreversibly bound by catalytic antibody; autoimmune disease; a lymphoproliferative disorder; anticarcinogenic, -tumor, -inflammatory agents |
| 01/31/2002 | US20020012948 Metallopeptide combinatorial libraries and applications |
| 01/31/2002 | US20020012631 As imaging agents for the diagnosis of cardiovascular disorders such as thromboembolic disease or atherosclerosis, infectious disease and cancer |
| 01/31/2002 | CA2797652A1 Multi-component biological transport systems |